anti-TNIIIA2 antibodies (Tokyo University of Science)

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug Nameanti-TNIIIA2 antibodies (Tokyo University of Science)
Drug Alias NameLSP-52LSP-75
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionTenascin inhibitors
TargetsTenascin
Therapy Area/IndicationsInflammationNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTokyo University of Science
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTokyo University of Science
Active IndicationsN/A
Inactive IndicationsInflammationNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A